Skip to main content
Signal8

THANGARAJ IMMANUEL

SEC insider (Form 3/4/5 filer). CIK 0001213308. Director at ACURA PHARMACEUTICALS, INC (ACUR). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in PALATINE, IL.

Companies THANGARAJ IMMANUEL has filed insider reports for

  • ACURA PHARMACEUTICALS, INC (ACUR): Director
THANGARAJ IMMANUEL profile photo

THANGARAJ IMMANUEL

CIK: 0001213308

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (50.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACURA PHARMACEUTICALS, INC logo
ACUR

ACURA PHARMACEUTICALS, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ACURA PHARMACEUTICALS, INC logo
    ACUR

    ACURA PHARMACEUTICALS, INC

    Jan 2, 2026
    Exercise
    Direct
    50K shares-
  • ACURA PHARMACEUTICALS, INC logo
    ACUR

    ACURA PHARMACEUTICALS, INC

    Jan 2, 2026
    Award

    Restricted Stock Units (2021 Plan)

    Direct
    50K shares-
  • ACURA PHARMACEUTICALS, INC logo
    ACUR

    ACURA PHARMACEUTICALS, INC

    Jan 2, 2025
    Exercise
    Direct
    50K shares-
  • ACURA PHARMACEUTICALS, INC logo
    ACUR

    ACURA PHARMACEUTICALS, INC

    Jan 2, 2025
    Award

    Restricted Stock Units (2021 Plan)

    Direct
    50K shares-

1-4 of 4